Inspire Veterinary Partners (IVPR) AI Stock Analysis

503 Followers

Inspire Veterinary Partners

(Other OTC:IVPR)

Select Model

Rating:38.2Underperform

Price Target:$0.03▲(31900.00% Upside)

Action:reiterated

Date:01/22/26

The score is driven primarily by weak financial performance (negative profitability, high leverage, and negative operating/free cash flow) and bearish technical signals (below major moving averages with negative MACD). Additional downside risk comes from Nasdaq delisting and OTCQB move, while valuation is difficult to support due to a negative P/E and no dividend yield data.

Positive Factors

Strategic Growth InitiativesThe consulting agreement with 622 Capital LLC aims to enhance financial positioning and strategic growth, supporting long-term business development.

Negative Factors

High LeverageHigh leverage can increase financial risk and limit flexibility, potentially impacting long-term financial stability and growth opportunities.

Inspire Veterinary Partners (IVPR) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $11.89K
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 0.0
Beta (1Y): 9.55
Revenue Growth: ―
EPS Growth: ―
Country: US
Employees: 113
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Agricultural - Commodities/Milling

Inspire Veterinary Partners Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. manages and owns a network of veterinary hospitals located across the United States. The company's primary focus is general practice for small animals, catering to beloved companion pets like dogs and cats, with thei...

How the Company Makes Money

Inspire Veterinary Partners generates revenue primarily by charging clients (pet owners) for veterinary medical services provided at its hospitals. Key revenue streams generally include (1) professional service fees for office visits, examinations, a...

Inspire Veterinary Partners Financial Statement Overview

Summary

Overall financials are weak: profitability remains negative (net profit and EBIT margins), gross margin has deteriorated year over year, leverage is high (elevated debt-to-equity and low equity ratio), and operating/free cash flow are negative—raising funding and stability risk despite slight revenue growth.

Income Statement

35Negative

Balance Sheet

25Negative

Cash Flow

40Negative

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2024	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	15.56M	16.59M	16.68M	9.83M	2.55M	0
Gross Profit	4.73M	3.29M	3.55M	2.55M	829.29K	0
EBITDA	-8.24M	-9.50M	-10.84M	-2.91M	-978.01K	0
Net Income	-11.94M	-14.26M	-14.79M	-4.91M	-1.33M	-5,520
Balance Sheet
Total Assets	23.96M	20.20M	21.79M	20.19M	6.33M	21.97K
Cash, Cash Equivalents and Short-Term Investments	341.75K	523.69K	178.96K	444.25K	2.06M	21.97K
Total Debt	13.94M	16.37M	18.42M	23.61M	6.69M	0
Total Liabilities	19.79M	18.63M	22.58M	25.32M	7.20M	0
Stockholders Equity	4.17M	1.56M	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow
Free Cash Flow	-4.34M	-10.24M	-4.20M	-2.84M	-2.32M	-5,520
Operating Cash Flow	-4.23M	-10.01M	-3.82M	-2.66M	-1.01M	-5,520
Investing Cash Flow	-1.96M	-237.98K	-1.87M	-14.67M	-4.02M	0
Financing Cash Flow	5.89M	10.59M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners Technical Analysis

Technical Analysis SentimentNegative

Last Price0.00

Price Trends

50DMA0.16Negative

100DMA0.54Negative

200DMA0.92Negative

Market Momentum

MACD-0.04Negative

RSI32.78Neutral

STOCH11.74Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVPR, the sentiment is Negative. The current price of 0.00 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.16, and below the 200-day MA of 0.92, indicating a bearish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 32.78 is Neutral, neither overbought nor oversold. The STOCH value of 11.74 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVPR.

Inspire Veterinary Partners Risk Analysis

Inspire Veterinary Partners disclosed 48 risk factors in its most recent earnings report. Inspire Veterinary Partners reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Inspire Veterinary Partners Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

IVPR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CON	80Outperform	$5.55B	24.86	47.30%	0.59%	14.02%	31.92%
LFST	72Outperform	$5.43B	70.61	4.82%	―	22.62%	―
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
SGRY	59Neutral	$2.98B	-33.58	-5.21%	―	3.99%	51.58%
ACHC	53Neutral	$3.00B	-2.79	-57.05%	―	4.47%	-1156.09%
PARK	48Neutral	$101.50M	-24.29	-18.26%	―	―	―
IVPR	38Underperform	$12.20K	0.00	-240.99%	―	―	―

* Consumer Cyclical Sector Average

Performance Comparison

IVPR and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IVPR	Inspire Veterinary Partners, Inc.	0.01	-0.73	-98.65%
ACHC	Acadia Healthcare Company, Inc.	34.79	15.28	78.32%
SGRY	Surgery Partners Inc.	23.17	1.67	7.77%
LFST	Lifestance Health Group, Inc.	13.43	7.14	113.51%
CON	Concentra Group Holdings Parent, Inc.	42.15	23.00	120.15%
PARK	Park Dental Partners, Inc.	20.14	9.89	96.49%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 21, 2026

Inspire Veterinary Partners AI Stock Analysis